Emerson Electric

EMR

156.2150.86% ( -1.355 )

Trading: Aug 25, 13:56:40 (EDT)

2026-W342026-08-17

EMR.US Weekly Report · 2026-W34

EMR declined 3.66% this week, closing at $157.26. Fundamentals have not deteriorated: Q3 earnings grew 23% YoY with net margin reaching 14.73%, a recent peak. Current PE of 34x sits at the near-one-year low percentile. The tension is evident: analyst upgrades and optimistic forecasts contrast with broad fund outflows, revealing a disconnect between near-term sentiment and medium-term bullish fundamentals.

Market Action

This week’s closing price of $157.26 represents a 3.66% decline from last week’s close of $163.17. The week’s range spanned $154.08 to $164.35, a swing of 10.27 points (6.3% intra-week volatility). Trading evolved as Monday-Thursday weakness followed by a Friday partial recovery, but the overall trend remained downward.

Volume metrics show average daily volume of 1.93 million shares this week, slightly below the typical 200-300 million range of the past 60 days—a mild pullback in activity. The turnover rate stands at 0.37%, indicating notably thin trading. Volume contraction during sharp reversals from recent highs often signals holders adopting a wait-and-see posture rather than panic selling.

Valuation and Earnings

Current PE is 34.04x with PB at 4.30x. Per the latest valuation snapshot, PE ranks at the 4.62nd percentile over the past year—meaning the current price has fallen to the lowest range in the last 12 months, with prices trading above this level roughly 95% of the time.

Q3 2026 results: EPS $1.28, +23% YoY; Revenue $4.873 billion, +7.03% YoY; Net income $718 million, +22.53% YoY; Net margin 14.73%, a six-quarter high. The numbers underscore not just growth acceleration but also improving profitability quality.

Consensus forecasts (latest snapshot) peg 2026 full-year EPS between 7.05 and 7.08, with a median of 7.075. With Q3 EPS already at $1.28, the full-year trajectory aligns with consensus expectations.

Capital Flows and Institutional Views

Capital flows turned decidedly negative across the board. As of August 21, large funds registered net outflows, mid-tier capital net outflows exceeded 480 units, and retail net outflows totaled 380 units. The pattern reflects passive selling or a cautious stance, reinforcing the price decline.

On the institutional side, 15 analysts rate the stock “buy,” 8 rate “hold,” 1 rates “sell,” and others rate 1 each. The consensus rating is “buy” with a target price of $171.44, implying roughly 9% upside from current levels. The rating was updated this past Thursday (August 21), reflecting sustained medium-to-long-term optimism. However, target prices and ratings often lag near-term market adjustments.

Weekly News Digest

This week’s news centers on three threads: product/M&A developments, analyst rating updates, and major contract wins.

The most recent headline came Thursday when an analyst maintained a hold rating while raising long-term estimates and setting the target price at $155. Prior to this, Stephens analysts had lifted their price target to $160. This continuity suggests steady confidence among longer-horizon investors.

On the M&A and business front, Emerson secured a multi-million-dollar BP Shah Deniz Compression automation contract last month and completed its acquisition of Glue, bolstering AI-driven test-and-measurement software capabilities. These moves underscore the company’s strategic positioning in automation and AI toolchains—aligning with industry-wide shifts toward digitalization and intelligence.

On the institutional holding front, Deutsche Bank and Johnson Financial Group added or increased positions in EMR this week, signaling undiminished conviction from certain large asset managers.

Top 10 News Items This Week:

Signal Alignment and Tensions

This week reveals a classic mismatch between near-term sentiment and medium-term fundamentals:

Contradictory Signals:

Valuation: PE 34x at 4.62nd percentile over one year—pricing is already deeply discounted
Earnings: Q3 EPS +23% YoY, net margin 14.73% at six-quarter peak; growth accelerating
Institutional: 15 buy ratings, 9% upside to targets, ratings refreshed this week
Capital flows: Broad outflows exceeding 850 units, completely at odds with cheap valuation and bullish ratings

Aligned Bearish Signals:

Price action: Reversal from 164 high, 6.3% weekly swing, intra-week softness
Volume: Net outflows across all categories during the pullback

This divergence typically surfaces when markets pull back from prior gains and early profit-taking occurs. With valuation already at extremes and earnings accelerating, the broad fund outflows may reflect technical-level consolidation from a rapid advance rather than fundamental deterioration. The lag in analyst updates is also telling—ratings refreshed August 21 yet the stock had already repriced 3.66% lower by week’s end, suggesting markets were already repricing before official updates.

The next focal point: whether thin-volume retracements stabilize, and whether incremental capital recognizes the compressed valuation.